[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR0111055A - Formulação farmacêutica, e, processo para a preparação e uso da mesma - Google Patents

Formulação farmacêutica, e, processo para a preparação e uso da mesma

Info

Publication number
BR0111055A
BR0111055A BR0111055-1A BR0111055A BR0111055A BR 0111055 A BR0111055 A BR 0111055A BR 0111055 A BR0111055 A BR 0111055A BR 0111055 A BR0111055 A BR 0111055A
Authority
BR
Brazil
Prior art keywords
preparation
pharmaceutical formulation
formulations
butylnitrone
disulfophenyl
Prior art date
Application number
BR0111055-1A
Other languages
English (en)
Inventor
Mats J Andersson
Mattias Andersson
Patrik Eriksson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of BR0111055A publication Critical patent/BR0111055A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"FORMULAçãO FARMACêUTICA, E, PROCESSO PARA A PREPARAçãO E USO DA MESMA". São descritas novas formulações farmacêuticas de <244>-(2,4-dissulfofenil)-N-terc-butilnitrona e seus sais farmaceuticamente aceitáveis e o uso de tais formulações no tratamento de várias doenças e condições, especialmente de derrame.
BR0111055-1A 2000-05-23 2001-05-22 Formulação farmacêutica, e, processo para a preparação e uso da mesma BR0111055A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0001916A SE0001916D0 (sv) 2000-05-23 2000-05-23 Novel formulation
PCT/SE2001/001164 WO2001089507A1 (en) 2000-05-23 2001-05-22 NOVEL FORMULATIONS OF α-2,4-DISULFOPHENYL-N-TERT-BUTYLNITRONE

Publications (1)

Publication Number Publication Date
BR0111055A true BR0111055A (pt) 2003-04-15

Family

ID=20279797

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111055-1A BR0111055A (pt) 2000-05-23 2001-05-22 Formulação farmacêutica, e, processo para a preparação e uso da mesma

Country Status (30)

Country Link
US (2) US20030181527A1 (pt)
EP (1) EP1294369B1 (pt)
JP (1) JP3744857B2 (pt)
KR (1) KR20030001545A (pt)
CN (1) CN1268326C (pt)
AR (1) AR030218A1 (pt)
AT (1) ATE303803T1 (pt)
AU (2) AU2001260935B2 (pt)
BR (1) BR0111055A (pt)
CA (1) CA2408781A1 (pt)
CZ (1) CZ20023849A3 (pt)
DE (1) DE60113255T2 (pt)
DK (1) DK1294369T3 (pt)
EE (1) EE200200653A (pt)
ES (1) ES2247112T3 (pt)
HK (1) HK1051649A1 (pt)
HU (1) HUP0302310A3 (pt)
IL (1) IL152533A0 (pt)
IS (1) IS6610A (pt)
MX (1) MXPA02011533A (pt)
MY (1) MY130445A (pt)
NO (1) NO20025461D0 (pt)
NZ (1) NZ522329A (pt)
PL (1) PL361284A1 (pt)
RU (1) RU2271800C2 (pt)
SE (1) SE0001916D0 (pt)
SK (1) SK16542002A3 (pt)
TW (1) TWI259078B (pt)
WO (1) WO2001089507A1 (pt)
ZA (1) ZA200208747B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050182060A1 (en) * 2004-02-13 2005-08-18 Kelly Michael G. 2-Substituted and 4-substituted aryl nitrone compounds
US10005830B2 (en) 2009-03-05 2018-06-26 Ablynx N.V. Antigen binding dimer-complexes, methods of making/avoiding and uses thereof
US9265834B2 (en) 2009-03-05 2016-02-23 Ablynx N.V. Stable formulations of polypeptides and uses thereof
EP2470015B1 (en) 2009-08-24 2016-01-13 Hough Ear Institute Nitrone compounds for treating sensorineural hearing loss
LT2805731T (lt) * 2009-09-03 2019-02-11 Ablynx N.V. Stabilios polipeptidų kompozicijos ir jų panaudojimas
EP2512489A4 (en) * 2009-12-15 2014-04-02 Merck Sharp & Dohme METHOD OF PREPARING ACADESINE
AU2012211989B2 (en) * 2011-02-04 2017-03-02 Hough Ear Institute Methods for treating brain injury
EP2911648B1 (en) * 2012-10-25 2017-02-01 Fresenius Kabi Oncology Limited Stable pharmaceutical composition of 5-aza-2'peoxyotipine
US10660851B2 (en) 2015-01-02 2020-05-26 Rxos Medical Polyfunctional radical scavenger hydrogel formulation
CN116650411A (zh) * 2022-02-25 2023-08-29 广州喜鹊医药有限公司 一种注射用硝酮嗪药物组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960008230B1 (ko) * 1989-10-17 1996-06-21 윌리엄 쥐.씨먼 중추신경계의 산화적 손상에 관련된 질병들을 억제하기 위한 조성물들
JP2813023B2 (ja) * 1990-03-13 1998-10-22 株式会社神戸製鋼所 Ｍｉｓ型ダイヤモンド電界効果トランジスタ
US5488145A (en) * 1993-12-23 1996-01-30 Oklahoma Medical Research Foundation 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps

Also Published As

Publication number Publication date
CZ20023849A3 (cs) 2003-05-14
KR20030001545A (ko) 2003-01-06
US20080161406A1 (en) 2008-07-03
JP2003534276A (ja) 2003-11-18
SE0001916D0 (sv) 2000-05-23
AU2001260935B2 (en) 2005-05-19
DE60113255T2 (de) 2006-06-08
NO20025461L (no) 2002-11-14
CN1268326C (zh) 2006-08-09
ES2247112T3 (es) 2006-03-01
DK1294369T3 (da) 2005-11-14
IS6610A (is) 2002-11-11
RU2271800C2 (ru) 2006-03-20
TWI259078B (en) 2006-08-01
CN1430510A (zh) 2003-07-16
NO20025461D0 (no) 2002-11-14
NZ522329A (en) 2004-07-30
JP3744857B2 (ja) 2006-02-15
ATE303803T1 (de) 2005-09-15
CA2408781A1 (en) 2001-11-29
PL361284A1 (en) 2004-10-04
EE200200653A (et) 2004-06-15
RU2002129588A (ru) 2004-03-27
WO2001089507A1 (en) 2001-11-29
MY130445A (en) 2007-06-29
HK1051649A1 (en) 2003-08-15
MXPA02011533A (es) 2003-04-25
EP1294369A1 (en) 2003-03-26
SK16542002A3 (sk) 2003-04-01
HUP0302310A2 (hu) 2003-11-28
AU6093501A (en) 2001-12-03
EP1294369B1 (en) 2005-09-07
DE60113255D1 (de) 2005-10-13
AR030218A1 (es) 2003-08-13
ZA200208747B (en) 2004-02-10
US20030181527A1 (en) 2003-09-25
HUP0302310A3 (en) 2005-06-28
IL152533A0 (en) 2003-05-29

Similar Documents

Publication Publication Date Title
BR0211289A (pt) Derivados de dolastatina 10
HRP20020880B1 (en) New pharmaceutical composition
BR0111016A (pt) Composições farmacêuticas de liberação sustentada para a administração parenteral de compostos hidrófilos biologicamente ativos
BR0012590A (pt) Composto, processo para a preparação do mesmo, formulação farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de dor ou desconforto, e para tratamento ou profilaxia de dor neuropática ou central
BR0207760A (pt) Composição farmacêutica, uso da mesma, métodos para o tratamento de dor e de inflamação, e, processo para a preparação de uma composição
BR9911160A (pt) Ciclosporinas
BR0109272A (pt) Agentes conjugados terapêuticos de ácido poliglutâmico, métodos para suas preparações e usos
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
BR0112962B1 (pt) Composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos
BR0113822A (pt) Vacina
SE9904505D0 (sv) Novel compounds
ATE218582T1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen
AR024227A1 (es) Pirimidinas inhibidoras de replicacion de hiv, un proceso para su preparacion, el uso de las mismas para la manufactura de un medicamento, composiciones farmaceuticas, y un proceso para prepararlas
DK1036059T3 (da) Adamantanderivater
EE200200486A (et) Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, uued derivaadid ja nende valmistamismeetodid
BRPI0113331B8 (pt) derivados de fenilalanina ou seus sais parmaceuticamente aceitáveis, antagonista de integrina alfa 4, agente terapêutico ou agente preventivo para doenças inflamatórias, e, composição farmacêutica
EE200000320A (et) Uudsed ühendid
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
BR0214243A (pt) Derivado de sulfonamida processo para a preparação de um derivado de sulfonamida e seus sais fisiologicamente aceitáveis, composição farmacêutica e uso de um derivado de sulfonamida
ES2157993T3 (es) Benzoilguanidinas, su preparacion y su uso en medicamentos.
TR200200716T2 (tr) Ketiyapin granülleri
AR019496A1 (es) Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos
BR9801150A (pt) Derivados de propanolamina, processos para a preparação deles, produtos farmacêuticos compreendendo esses compostos e uso dos mesmos.
BR0113291A (pt) steres de aporfina e seu uso em terapia
BR0111055A (pt) Formulação farmacêutica, e, processo para a preparação e uso da mesma

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9AANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2064 DE 27/07/2010.